| 摘要 |
Provided is a method of evaluating (predicting) differences between individuals in drug sensitivity or vulnerability to diseases, using a voltage-dependent calcium channel polymorphism. The method of evaluating vulnerability to diseases and the method of evaluating drug sensitivity according to the present invention are characterized by relating vulnerability to diseases and drug sensitivity of individuals to a voltage-dependent calcium channel polymorphism, or a haplotype comprising said polymorphism. |
